| Items | Drug Registration information |
|---|---|
| ID | 900 |
| No | 900 |
| Brand Name | DABRAMAKS 75 |
| Ingredients | DABRAFENIB 75 MG |
| Dosage Form | CAPSULE |
| Primary Packaging | BOTTLE |
| Storage | |
| Shelf Life | 3 YEARS |
| Pack Size | 120 TABLETS/BOTTLE |
| Dispensing Category | |
| ATC Classification | |
| Pharmaceutical Class | |
| Indications | BRAF V600E MUTATION-POSITIVE UNRESECTABLE OR MEATASTATIC MELANOMA, MUTATION-POSITIVE METASTATIC NSCLC |
| Contraindications | |
| Side Effects | |
| Unit Price | |
| EDL | NULL |
| Description | WHITE CAPSULE CONTAINS WHITE GRANULE |
| Note | |
| License Owner | FACTORY NO.2 |
| Manufacturer | FACTORY No.2 |
| Country | LAOS |
| Import Registration No | |
| Import Registration Date | |
| Activity | CERTIFICATE RELEASED |
| Applied Date | |
| FDD Registration No | 12 L 1044/23 |
| FDD Registration Date | 15/12/2023 |
| Expiry Date | 14/12/2026 |